EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Therapeutic Potential and Predictive Pharmaceutical Modeling of Indole Kratom Alkaloids

Md Harunur Rashid, Matthew J. Williams, Andres Garcia Guerra, Arunporn Itharat, Raimar Loebenberg, Neal M. Davies

Journal of Phytomedicine · 2025

DOI: 10.3390/jphytomed1010001 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Phytomedicine, 2025. Verfasst von Md Harunur Rashid und 5 weiteren Autor:innen. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 67 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: MITAC.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kratom alkaloids are classified as aromatic pentacyclic indole and substituted carbonyl oxindole alkaloids. This study investigates the metabolism and interactions of indole alkaloids using in silico tools, including ADMET Predictor 13.0™, to assess pharmacokinetic and metabolic profiles. The analysis examined absorption, distribution, metabolism, and excretion (ADME), focusing on cytochrome P450 (CYP) and UDP-glucuronosyltransferase (UGT) enzyme interactions, drug transporters, and clearance. Most indole alkaloids showed strong substrate interaction and inhibition of CYP3A4 (79–99% confidence) and induction of CYP1A2 (up to 94% confidence). Among UGT enzymes, UGT1A1 demonstrated the highest substrate affinity (97%), while none interacted with UGT2B15. All alkaloids showed strong P-glycoprotein (Pgp) interaction but minimal inhibition of BCRP. Mitralactonine exhibited the highest skin permeability, and Mitralactonal showed maximal jejunal permeability. Most indole alkaloids demonstrated significant blood–brain barrier penetration (up to 99% confidence) and compliance with Lipinski’s rule of five. Predictive modeling indicated notable effects on hepatic microsomal clearance parameters. This investigation offers the first comprehensive in silico ADMET profiling of kratom indole alkaloids, uncovering their CYP3A4 inhibition potential and metabolic liabilities to prioritize candidates for safer therapeutic development, though limited by model biases, applicability domain restrictions, and inability to fully capture biological complexity, stereochemistry, or interindividual variability necessitating experimental in vitro and in vivo validation.

Förderung

  • MITAC

Zitieren

APA

Rashid, M. H., Williams, M. J., Guerra, A. G., Itharat, A., Loebenberg, R., & Davies, N. M. (2025). Therapeutic Potential and Predictive Pharmaceutical Modeling of Indole Kratom Alkaloids. Journal of Phytomedicine. https://doi.org/10.3390/jphytomed1010001

Vancouver

Rashid MH, Williams MJ, Guerra AG, Itharat A, Loebenberg R, Davies NM. Therapeutic Potential and Predictive Pharmaceutical Modeling of Indole Kratom Alkaloids. Journal of Phytomedicine. 2025. doi:10.3390/jphytomed1010001

BibTeX
@article{Rashid2025,
  author = {Rashid, Md Harunur and Williams, Matthew J. and Guerra, Andres Garcia and Itharat, Arunporn and Loebenberg, Raimar and Davies, Neal M.},
  title = {Therapeutic Potential and Predictive Pharmaceutical Modeling of Indole Kratom Alkaloids},
  journal = {Journal of Phytomedicine},
  year = {2025},
  doi = {10.3390/jphytomed1010001}
}
Kostenlos starten →